Glifo Tablet 25 mg contains Empagliflozin, a SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor, designed for the management of type 2 diabetes mellitus. Empagliflozin works by blocking glucose reabsorption in the kidneys, promoting its excretion through urine, which helps lower blood sugar levels effectively.

Glifo Tablet 25 mg is particularly useful for adults with type 2 diabetes who are not achieving optimal glycemic control through diet, exercise, or other antidiabetic medications. By helping maintain stable blood glucose levels, Glifo also contributes to weight management and cardiovascular health, providing additional benefits beyond glycemic control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Glifo Tablet 25 mg is indicated for:

• Type 2 diabetes mellitus to improve glycemic control

• Can be used as monotherapy when diet and exercise alone are insufficient

• Can be used in combination with other oral hypoglycemic agents or insulin for enhanced glucose control

• Suitable for adults with high cardiovascular risk, as Empagliflozin has been shown to reduce the risk of cardiovascular events in certain patients

It is not indicated for type 1 diabetes or diabetic ketoacidosis.

Mechanism of Action

• SGLT2 inhibition: Empagliflozin blocks Sodium-Glucose Cotransporter-2 in the proximal renal tubules, preventing glucose reabsorption.

• Glucosuria promotion: Excess glucose is excreted in the urine, lowering plasma glucose levels independently of insulin.

• Caloric loss: Increased urinary glucose excretion may contribute to modest weight reduction.

• Cardiovascular and renal benefits: Empagliflozin has been shown to reduce cardiovascular risk and improve renal outcomes in patients with type 2 diabetes.

• Low hypoglycemia risk: Since the mechanism is insulin-independent, the risk of hypoglycemia is lower compared to some other antidiabetic agents.

Dosage and Administration

• Adults: 1 tablet (25 mg) once daily, with or without food, preferably taken at the same time each day.

• Dose adjustments may be required in patients with renal impairment; consult a healthcare professional.

• Maintain regular monitoring of blood glucose and HbA1c for optimal management.

• Continue with dietary modifications, exercise, and lifestyle measures alongside medication.

Benefits and Features

• Effectively lowers fasting and postprandial blood glucose

• Provides weight management support through mild caloric loss

• Reduces cardiovascular risk in high-risk type 2 diabetes patients

• Works independently of insulin, reducing hypoglycemia risk

• Convenient once-daily dosing

• Can be used alone or in combination therapy for enhanced glucose control

Side Effects

Glifo Tablet 25 mg is generally well tolerated. Common side effects may include:

• Increased urination due to glucosuria

• Mild thirst or dehydration

• Genital or urinary tract infections (more common in women)

• Rarely, hypotension or electrolyte imbalance

Seek medical advice if severe dehydration, persistent infections, or other serious adverse effects occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not recommended for type 1 diabetes or diabetic ketoacidosis

• Use caution in patients with renal impairment or hypotension

• Maintain adequate hydration to prevent dehydration

• Inform your healthcare provider of all medications to avoid drug interactions

• Regularly monitor blood glucose, renal function, and electrolytes during therapy

Storage Conditions

Store Glifo Tablet 25 mg in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep the container tightly closed and out of reach of children.

Glifo Tablet 25 mg is an effective and modern oral antidiabetic that helps control blood glucose, support weight management, and provide cardiovascular protection, making it an ideal choice for adults with type 2 diabetes seeking comprehensive glycemic management.